July 2025 Life Sciences Mega Close: Frazier Life Sciences Closes $1.3B Fund XII
Frazier Life Sciences closed Fund XII at over $1.3 billion on July 31, 2025 — one of the largest biotech venture funds closed in July 2025.
Understanding venture capital market dynamics helps founders time their raises and helps investors spot durable themes. Our market analysis covers deal flow, sector concentration, valuation benchmarks, and geographic shifts across the global startup ecosystem.
Browse market analysis articles for data-driven insight into venture capital trends.
Frazier Life Sciences closed Fund XII at over $1.3 billion on July 31, 2025 — one of the largest biotech venture funds closed in July 2025.
Greenwich and Miami-based Glade Brook Capital closed Strategic Growth Fund IV at $515 million on July 22, 2025, targeting FinTech, AI, SpaceTech, and DefenseTech growth equity.
New York-based Quartus Capital Partners closed its Quartus AI Fund LP at $50M+ on July 14, 2025, deploying into growth-stage AI ventures across healthcare, education, and logistics.
San Francisco-based Propel Venture Partners closed Fund V at $100 million on July 11, 2025, bringing total commitments to $436M+ for fintech infrastructure seed investing.
Comprehensive June 2025 fund close tracker covering 67 newly closed venture and private equity vehicles — with NYC highlights including Galaxy Ventures, Greenbelt Capital, and Base10.
San Francisco-based Counterpart Ventures closed Fund III at $132 million on June 25, 2025, bridging 650+ corporate VCs with enterprise AI-native startups.